nivolumab,ipilimumab
bms
['melanoma', 'nivipi']
 iv anti-pd-1 + intralesional anti-ctla-4 in #melanoma? exciting presentation of the #nivipit study by aurelien marabelle at #esmoimmuno22 
Medical Doctor & Oncology Resident @SanMartino_Ge Melanoma & Skin Cancer, Immunotherapy | Italia???????????